Back

Which drugs to select and which to avoid in a patient with microalbuminuria

29 August 2026 (18:15 - 18:30)
Organised by: Logo
Congress Presentation Part of: Albuminuria as a clinical compass: guideline-driven approaches to cardiorenal protection Risk Factors and Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pauline Anne Swift

Epsom and St Helier NHS Trust Hospital, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Testing for albuminuria to prevent cardiovascular disease
Professor R. Gansevoort (Groningen, NL)
Presentation thumbnail
Albuminuria-based guideline implementation to improve cardiovascular outcomes
Professor C. Wanner (Wuerzburg, DE)
Presentation thumbnail
How to manage albuminuria in primary care
Doctor S. Claudel (Boston, US)

Access the full session

Session thumbnail
Albuminuria as a clinical compass: guideline-driven approaches to cardiorenal protection

The Event

Event poster

ESC Congress 2026

29 August 2026 18:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes
28 August 2022
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025
thumbnail
Congress Presentation
Renal and cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis
1 September 2019
thumbnail
Congress Session
Case-based discussion: chronic heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources